What SF68 is and how it differs from generic Enterococcus claims
Enterococcus faecium SF68 is a single defined strain identified by collection number NCIMB 10415, originally isolated from healthy human stool and characterized for industrial probiotic use in the 1980s. It is the probiotic in Purina Pro Plan FortiFlora (a daily veterinary supplement marketed for canine and feline GI support) and in Purina Pro Plan Veterinary Diets EN Gastroenteric (a therapeutic diet for dogs with GI disease). On AAFCO-compliant labels, SF68 is identified by full strain name including the NCIMB collection number; vague "Enterococcus faecium" claims without a collection number do not transfer the SF68 evidence base.
The genus Enterococcus matters because some Enterococcus species carry virulence factors and transferable antibiotic resistance, particularly hospital-associated E. faecium and E. faecalis strains. SF68 was specifically characterized by Marciluk 2007 and Vahjen 2007 as virulence-gene-negative and as lacking transferable resistance genes. The European Food Safety Authority maintains SF68 on the Qualified Presumption of Safety (QPS) list per EFSA 2023 update, the regulatory standard for generally-recognized-as-safe probiotic strains in the EU. AAFCO 2024 Direct-Fed Microbials Guidelines, finalized after the 2022 working group, now require strain identity for any probiotic claim on a U.S. pet food label, partly because of this Enterococcus-genus safety concern.
Mechanism — lactic acid, bacteriocins, and pathogen exclusion
SF68 exerts probiotic effects through three mechanisms. First, it produces lactic acid from carbohydrate fermentation across both small intestine and large intestine, lowering luminal pH and creating an environment unfavorable to pathogens including Clostridium perfringens, salmonella species, and pathogenic Escherichia coli per Suchodolski 2021 (Vet Clin North Am Small Anim Pract microbiome review). Second, SF68 produces enterocin-class bacteriocins that directly inhibit gram-positive pathogens via membrane pore formation per Marcinakova 2006 (FEMS Microbiol Letters). Third, SF68 stimulates IgA production by gut-associated lymphoid tissue and modulates regulatory T-cell populations per Stuyven 2009 (Vet Immunol Immunopathol), enhancing mucosal immune response without driving systemic inflammation.
The unusual property of SF68 versus other probiotic strains is its activity across both small and large intestine. Lactobacillus acidophilus colonizes primarily the small intestine and Bifidobacterium animalis primarily the large intestine; SF68 has documented activity in both sites per Vahjen 2007. This broader site distribution is one reason it is often used as a single-strain veterinary probiotic where multi-strain blends might otherwise be needed. See our L. acidophilus explainer and B. animalis explainer for the site-of-action contrast.
Canine clinical evidence — Bybee 2011 and beyond
The canonical SF68 canine reference is Bybee 2011 (JVIM), a randomized controlled trial in 217 shelter dogs at four U.S. shelters. Dogs randomized to SF68 supplementation at 108 CFU/day had a statistically significant reduction in diarrhea incidence compared to placebo, particularly during the high-stress first two weeks after intake. Per Schmitz 2017 (J Anim Physiol Anim Nutr), SF68 supplementation in dogs with chronic enteropathy improved fecal consistency scores and reduced clinical activity scores when combined with dietary management. Per Marciluk 2007 (Vet Microbiol), SF68 administration to healthy adult dogs increased fecal lactobacilli counts and reduced clostridial counts within 7 days, consistent with the proposed competitive-exclusion mechanism.
Per AAHA 2022 GI consensus statement, SF68 is rated low-to-moderate evidence for the indications above, with the moderate end of the range reflecting the unusually large body of canine-specific data versus other probiotic strains. Per ACVIM 2022 chronic enteropathies consensus, SF68 is one of the few probiotic strains specifically named in the consensus document as a reasonable adjunct to dietary trials and immunomodulatory therapy. None of this is monotherapy — SF68 supplementation does not replace appropriate diagnostic workup, dietary management, or pharmacotherapy where indicated.
Dose, viability, and AAFCO 2024 labeling
Therapeutic SF68 dosing per AAHA 2022 targets 109 to 1010 CFU per day, distributed across one or two meals. Purina Pro Plan FortiFlora is dosed as a single 1-gram sachet per day, declaring 108 CFU/g at end of shelf life; therapeutic doses per Bybee 2011 used the same 108 CFU/day target. SF68 is unusually robust to extrusion, gastric acid, and shelf-life decay versus many other probiotic strains per Aldrich 2006 (Petfood Industry), which is part of why Purina selected it for the FortiFlora product line.
AAFCO 2024 Direct-Fed Microbials Guidelines require pet food labels carrying probiotic claims to declare (a) strain identity by collection number (E. faecium NCIMB 10415 for SF68), (b) guaranteed minimum CFU per gram at end of shelf life rather than at manufacture, and (c) the assumed storage conditions for the shelf life calculation. Foods that meet all three are dose-verifiable. Foods that declare only "probiotics" or "Enterococcus faecium" without a collection number do not transfer the SF68 evidence base regardless of marketing claims, and are scored conservatively in the KibbleIQ rubric.
How KibbleIQ scores E. faecium SF68
The KibbleIQ Dry Kibble Rubric awards positive credit for probiotic inclusion when the label declares (a) strain identity (E. faecium NCIMB 10415, not just "E. faecium" or "probiotics"), (b) guaranteed minimum CFU per gram at end of shelf life per AAFCO 2024 DFM Guidelines, and (c) a strain with documented canine evidence (SF68 qualifies with the strongest canine evidence base of any single probiotic strain). SF68 inclusion earns a slightly higher positive than B. animalis or L. acidophilus inclusion because of the larger canine-specific evidence base. Foods that pair SF68 with prebiotic substrates — fructooligosaccharides, inulin, or beet pulp — earn additional credit because the prebiotic provides fermentation substrate.
Foods relevant to SF68-supported nutrition include those formulated for sensitive stomachs and stress-related dysbiosis — see best dog food for sensitive stomachs. To check what your dog is getting, paste the ingredient list into the KibbleIQ analyzer. Adding a SF68 supplement on top of a complete diet should always involve the prescribing veterinarian per ACVIM 2022, particularly during transitions to a novel diet, after antibiotic therapy, or during boarding/travel stress windows.